Creative Peptides

Trust, but Verify

Or, R.I.P, CoA.

Emil W. Ciurczak, DoraMaxx Consulting 09.09.21

APIs | Drug Development

API Development Trends

Why is it important to consider solid form in API development?

John Mykytiuk, Jamie Marshall and Andrew Blythe-Dickens, Sterling Pharma Solutions 09.09.21

APIs | Solid Dosage/Creams/Ointments

Spray Drying: A Proven Approach to Enhance the Solubility of APIs

Spray drying is an established particle engineering technology that offers several advantages over other methods used for improving API bioavailability.

Benzion Dolitzky, PhD, VP R&D, Wavelength Pharmaceuticals 09.09.21

APIs | Clinical Trial Materials

Outsourcing the Manufacture of Clinical Trial APIs

What to consider when deciding to partner with a CDMO for manufacturing.

Josh Hoerner, General Manager, Purisys 09.09.21

Logistics | Supply Chain

Maintaining Critical Drug Supply During COVID-19

Vincent Colicchio from Dr. Reddy’s talks about the challenges and solutions of maintaining supply during the pandemic.

Tim Wright, Editor, Contract Pharma 09.09.21

Choosing and Managing a CDMO

Speed up your time-to-market, keep development costs under control and smooth the FDA approval and commercial launch process.

Dana Toops, President, Avema Pharma Solutions 09.09.21

Analytical Services | Bioanalytical Services

Putting Laboratory Suppliers to the Test in the COVID Era – and Beyond

Build resiliency into analytical methods through careful consideration of chromatography partners.

Hazel Dickson, PhD, Marketing Manager, Chemistry Group, Waters Corporation 09.09.21

APIs

Propofol – A Bachem Success Story

The COVID-19 pandemic has rapidly expanded awareness of the API Propofol, produced by Bachem in Vionnaz.

Bachem and Novo Nordisk Redesign SPPS for Green Chemistry

Replacing gold standard solvents to provide a greener alternative.

Breaking News | Facilities | Industry News

Xellia’s Cleveland Manufacturing Facility is Commercially Operational

Site producing key anti-infective drug products for U.S. hospitals and patients.

08.20.21

APIs | Breaking News | Facilities | Industry News

Curia to Expand U.S. Commercial Manufacturing Capability

Roughly $35 million will be invested to expand manufacturing and product-handling solutions for complex small molecules.

08.19.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Biotage Opens New UK Facility

Triples production capacity for equipment crucial in the supply chain for the production of mRNA vaccines.

08.17.21

APIs

Generic APIs from Bachem

Bachem covers the entire life cycle of an active pharmaceutical ingredient (API). View all of our generic APIs here.

APIs

Generic APIs Portfolio

With almost 50 years of expertise in peptide and small molecule synthesis, Bachem has an outstanding track record in large-scale manufacturing.

APIs | Drug Development

VideoBites: Pfizer CentreOne

Pfizer CentreOne® is a global CDMO embedded within Pfizer and a leading supplier of specialty APIs.

The Real Cost of Bringing Manufacturing Home

Bikash Chatterjee of Pharmatech Associates discusses the reshoring trend, technologies and advances that could help deliver more manufacturing back to the U.S.

08.04.21

Breaking News | Clinical Trials | Drug Development | Industry News | Information Technology

Almac, THREAD to Integrate Technologies for Clinical Trials

Integrating technology platforms aims to provide sponsors and CROs with a full range of tools designed to reduce the risk of trial delays.

07.28.21

Breaking News | Facilities | Industry News

Archimica Completes Expansion of Its Multi-Purpose Manufacturing Capacity

Recent investment adds significantly to the company's capabilities.

07.27.21

Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News

Marvel Biotechnology Begins cGMP Manufacturing of Lead Candidate

Enters manufacturing agreement with Ausun Pharma for lead asset MB-204.

07.22.21

APIs | Breaking News | cGMP Manufacture | Industry News

MediPharm Labs Receives Canadian GMP Pharmaceutical DEL

License can be used for manufacturing, testing and sale of APIs and pharmaceutical drug products containing cannabis.

07.15.21

APIs | Cytotoxics and High Potency Manufacturing | Drug Development

Leverage the Benefits of Biocatalysis with the Right API CDMO

A powerful tool for organic synthesis, enzymatic chemistry has become an established methodology for manufacturing APIs.

Aseptic Processing | Breaking News | Fill/Finish | Industry News | Parenterals

Swiss Government Turns to Swissfillon for COVID-19 Test Kit Production

Drug product CMO specialist adapts to provide 0.8 million prefilled syringes.

07.08.21

APIs | Breaking News | GMPs/GCPs | Industry News | QA/QC

Purisys Obtains Two Global ISO Certifications

Now certified for ISO 17025 for Testing and Calibration Laboratories and ISO 17034 for Reference Material Producers.

07.08.21

APIs | Formulation Development

Shaping the Future of Formulation Development with Melt-based 3D Printing Technologies

In this white paper, the use of 3D printing is explored, with a focus on enhancement of bioavailability of APIs in solid dispersions.

Breaking News | Collaborations & Alliances | Facilities | Industry News

WuXi STA Chooses Middletown Delaware for New Pharma Manufacturing Campus

The CDMO is bringing about 500 jobs to Middletown, with site expected to open in 2024.

06.29.21

APIs | Supply Chain

Maintaining Critical Drug Supply During the Pandemic

Vin Colicchio from Dr. Reddy’s talks about the challenges and solutions of maintaining supply during the pandemic.

Tim Wright, Editor, Contract Pharma 06.17.21

Breaking News | Industry News

Biovectra Inc. Unveils New Logo and Brand

New image reflects the growing company’s full suite of expertise and core values.

Charles Sternberg, Assistant Editor 06.03.21

APIs | Cytotoxics and High Potency Manufacturing | Formulation Development | Process Development

Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion

Efficient processing and production technology for solid molecular dispersion, HME can provide sustained, modified and targeted drug delivery.

Ameya Deshpande, Formulation Scientist, Avomeen 05.25.21

HPAPI Development and Manufacturing Trends

The current trend of increased potency of drug substances is driving the need for better cleaning methods to reduce cross contamination.

05.20.21

Enteris BioPharma Completes Expansion of Manufacturing Facility

Also launches CDMO business for the development and manufacture of difficult to formulate drugs and highly potent compounds.

Tim Wright, Editor, Contract Pharma 05.11.21

Breaking News | Collaborations & Alliances | Industry News | Packaging & Tracking | Serialization

Yangtze River Pharmaceutical Group Selects TraceLink Solution to Aid Growth

Will use TraceLink’s applications and digital supply network to comply with track and trace requirements in multiple markets.

Charles Sternberg, Assistant Editor 05.07.21

CDMO Market Trends & Opportunities

CDMOs have been some of the biggest winners from COVID contracts and will see benefits for several more years to come. A Q&A with GlobalData’s Peter Shapiro.

Tim Wright, Editor, Contract Pharma 05.05.21

Small Molecule Drug Development Trends

Lonza’s Robert Beland discusses best practices for manufacturers to shorten development timelines, as well as some of the capabilities at the CDMO's Tampa site.

Tim Wright, Editor, Contract Pharma 05.05.21

TraceLink Introduces Opus Platform

Enables industries to work together with collective intelligence.

Charles Sternberg, Assistant Editor 04.21.21

Breaking News | Industry News

Revolo Biotherapeutics, CordenPharma Enter Master Service Agreement

Will scale up and manufacture ‘1104 for the treatment of eosinophilic esophagitis and allergic disease.

Charles Sternberg, Assistant Editor 04.19.21

Breaking News | Industry News

CordenPharma Colorado Enhances Lipid Purification Capacity

Announces another major capital expenditure initiative.

Charles Sternberg, Assistant Editor 04.19.21

Breaking News

KD Pharma Acquires Manufacturing Assets from Rohner AG

Expands its pharmaceutical contract manufacturing business.

Charles Sternberg, Assistant Editor 04.13.21

Enteris BioPharma: Custom Solutions – From Bench to Market

CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.

APIs | Breaking News | cGMP Manufacture | Industry News

Piramal Pharma to Acquire Indian API Manufacturer Hemmo

Adds peptide API development and manufacturing capabilities for growing number of oncology and metabolic therapies.

Kristin Brooks 04.01.21

Breaking News | Industry News

KD Pharma Acquires Rohner AG Manufacturing Assets

Acquisition expands KD Pharma’s CDMO capabilities.

Tim Wright, Editor, Contract Pharma 03.29.21

Breaking News | Capsules | Industry News

CapsCanada Launches Liquid-Filled Hard Capsule Mfg. Service in North America

New service aims to return pharmaceutical and OTC drug manufacturing back to North America.

Kristin Brooks 03.10.21

Manufacturing Equipment Trends

Andreas Mattern of Syntegon Technology discusses latest technologies being leveraged in manufacturing equipment today.

Kristin Brooks 02.25.21

Lonza Expands Solid Small Molecule Services

To encompass all aspects of solid form screening and characterization of small molecule APIs.

Kristin Brooks 02.16.21

Breaking News | Industry News

TCG Lifesciences Expands Footprint to the U.S.

Establishes CDMO subsidiary TCG GreenChem in New Jersey and Virginia.

Tim Wright, Editor, Contract Pharma 02.08.21

Parenterals

Parenteral Drug Delivery Trends

A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.

Kristin Brooks, Managing Editor, Contract Pharma 01.27.21

COVID-19 Impact Report

Leaders across the pharmaceutical contract services industry reflect on the impact of COVID-19 in 2020, and what to expect in 2021.

Tim Wright, Editor, Contract Pharma 01.27.21

Breaking News | Formulation Development | Industry News | Methods Development

Adare Pharma Solutions Opens New Small-Scale Lab

Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.

Kristin Brooks 01.26.21

Breaking News | Facilities | Industry News | Injectables | Parenterals

Civica to Build an Essential Medicines Manufacturing Facility in Virginia

Will produce sterile injectable meds used in hospitals for COVID-19 patient care.

Tim Wright, Editor, Contract Pharma 01.25.21

APIs | Breaking News | Facilities | Industry News

Sanofi Unveils EUROAPI as Name of New European API Company

Appoints Karl Rotthier as its future Chief Executive Officer.

Contract Pharma Staff 01.15.21

APIs | Breaking News | cGMP Manufacture | Fill/Finish | Industry News

LSNE Expands Fill Finish and Lyophilization Ops

New automated fill line at Bedford Campus adds ready-to-use aseptic filling and freeze-dryer capacity.

Contract Pharma Staff 01.14.21

Commercial Manufacturing

Syngene supports manufacturing of regulatory starting materials, APIs, HPAPI, NCEs and novel advanced intermediates.

Breaking News | Cytotoxics and High Potency Manufacturing | Drug Delivery | Facilities | Industry News

Inhalation CDMO Vectura Expands HPAPI Capabilities

New facility will increase containment operations at Chippenham, UK site.

Contract Pharma Staff 12.14.20

Logistics4Pharma Facility Passes Inspection

German logistics firm completes validation of GDP cold chain storage and transportation at Frankfurt facility.

Contract Pharma Staff 12.09.20

APIs | Breaking News | Clinical Trial Materials | Facilities | Industry News

Recipharm Expands API Manufacturing Capabilities

Invests $2.5 million in clinical GMP capacity for APIs at Israel facility.

Contract Pharma Staff 12.09.20

APIs | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Industry News

Piramal Invests $32M to Expand Michigan Facility

Includes additional capacity in Potent and Non-Potent API development and manufacturing.

Contract Pharma Staff 12.08.20

APIs | Drug Development | Drug Discovery

Why Do Integrated Services Matter?

From discovery to intermediates, APIs & drug products, a CDMO needs expertise across multiple elements of the pharma process to deliver an integrated experience